The Market Reports

Synopsis
The global market for Pharmaceutical Excipients was estimated to be worth US$ 45080 million in 2024 and is forecast to a readjusted size of US$ 64590 million by 2031 with a CAGR of 5.1% during the forecast period 2025-2031.
This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Pharmaceutical Excipients cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.
Pharmaceutical excipients are substances that are included in a pharmaceutical dosage form not for their direct therapeutic action, but to aid the manufacturing process, to protect, support or enhance stability, or for bioavailability or patient acceptability.
Global Pharmaceutical Excipients key players include Hnerkang、DowDuPont (FMC)、JRS Pharma、BASF、Lubrizol、Ashland、Croda International、Roquette、Shin-Etsu、Evonik, etc. Global top ten manufacturers hold a share about 7%. North America is the largest market, with a share about 35%, followed by Europe and Asia Pacific, have a share over 60 percent.
With the continuous progress and innovation of the pharmaceutical industry, the market demand for pharmaceutical excipients is also growing. Especially in the context of the improvement of global health awareness, the intensification of an aging society, and the increasing demand for efficient and safe drugs, the application scenarios of pharmaceutical excipients are becoming more and more extensive, and the market demand is expanding.
With the rise of new treatment methods such as biopharmaceuticals, personalized drugs, and targeted therapy, higher requirements are placed on the functions and performance of pharmaceutical excipients. For example, biologics and targeted drugs require specific excipients to improve the stability of drugs, improve the efficacy, or prolong the release time of drugs. In addition, the improvement of regulations and the improvement of industry standards have also promoted the standardized development of the pharmaceutical excipients market. In some regions, the government's supervision of drug quality has become more stringent, prompting pharmaceutical companies to pay more attention to quality and safety in the selection of pharmaceutical excipients, thereby promoting the demand for high-performance excipients.
This report aims to provide a comprehensive presentation of the global market for Pharmaceutical Excipients, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Pharmaceutical Excipients by region & country, by Type, and by Application.
The Pharmaceutical Excipients market size, estimations, and forecasts are provided in terms of sales volume (K Tons) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharmaceutical Excipients.
Market Segmentation
By Company
DowDuPont (FMC)
JRS Pharma
BASF
Lubrizol
Ashland
Croda International
Roquette
Shin-Etsu
Evonik
Associated British Foods
Südzucker AG
Mitsubishi
Hunan ER-KANG
Anhui Sunhere
Tianjin Chase Sun
Xiwang Group
ShengTai Group
Nanjing Well Pharmaceutical
Segment by Type
Starch and Derivatives
Sucrose
Cellulose and Derivatives
Dextrose
Polyols
Inorganic Salts
Others
Segment by Application
Oral Formulations
Topical Formulations
Parenteral Formulations
Other
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Pharmaceutical Excipients manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Pharmaceutical Excipients in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Pharmaceutical Excipients in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Index